Latest Trustworthy News from Dr. Mercola - delivered straight to your inbox!

Paxlovid Given License Inappropriately by FDA

May 25, the U.S. FDA approved Paxlovid to treat adults with mild or moderate COVID-19. Previously, Paxlovid was approved for emergency use authorization (EUA) only. But, according to Dr. Meryl Nass’ Substack blog, the licensing was done under questionable circumstances, with Pfizer cherry-picking just two clinical trials, both of which are questionable in and of themselves, to submit as evidence in the drug’s favor. Pfizer also for undisclosed reasons chose not to post any data...